Abstract:Abstract Motivation The task of predicting drug-target interactions (DTIs) plays a significant role in faciliating the development of novel drug discovery. Compared with laboratory-based approaches, computational methods proposed for DTI prediction are preferred due to their high-efficiency and low-cost advantages. Recently, much attention has been attracted to apply different graph neural network (GNN) models to discover underlying DTIs from hetergeneous biological information network (HBIN). Although GNN-based prediction methods achieve better performance, they are prone to encounter the over-smoothing simulation when learning the latent representations of drugs and targets with their rich neighborhood information in HBIN, and thereby reduce the discriminative ability in DTI prediction. Results In this work, an improved graph representation learning method, namely iGRLDTI, is proposed to address the above issue by better capturing more discriminative representations of drugs and targets in a latent feature space. Specifically, iGRLDTI first constructs a HBIN by integrating the biological knowledge of drugs and targets with their interactions. After that, it adopts a node-dependent local smoothing strategy to adaptively decide the propagation depth of each biomolecule in HBIN, thus significantly alleviating over-smoothing by enhancing the discriminative ability of feature represeantions of drugs and targets. Finally, a Gradient Boosting Decision Tree classifier is used by iGRLDTI to predict novel DTIs. Experimental results demonstrate that iGRLDTI yields better performance that several state-of-the-art computational methods on the benchmark dataset. Besides, our case study indicates that iGRLDTI can successfully identify novel DTIs with more distinguishable features of drugs and targets. Availability Python codes and dataset are available at https://github.com/stevejobws/iGRLDTI/. Supplementary information Supplementary data are available at Bioinformatics online.

Drug repurposing based on the DTD-GNN graph neural network: revealing the relationships among drugs, targets and diseases

Understanding Multivariate Drug-Target-DiseaseInterdependence Via Event-Graph.

DRTerHGAT: A Drug Repurposing Method Based on the Ternary Heterogeneous Graph Attention Network

A survey of drug-target interaction and affinity prediction methods via graph neural networks

Drug repositioning based on weighted local information augmented graph neural network

Gndd: A Graph Neural Network-Based Method For Drug-Disease Association Prediction

An effective drug-disease associations prediction model based on graphic representation learning over multi-biomolecular network

GraphDTA: predicting drug-target binding affinity with graph neural networks

Deep learning of multimodal networks with topological regularization for drug repositioning

Drug repositioning with adaptive graph convolutional networks

Graph theory enables drug repurposing. How a mathematical model can drive the discovery of hidden Mechanisms of Action

REDDA: Integrating multiple biological relations to heterogeneous graph neural network for drug-disease association prediction

Metapath-aggregated heterogeneous graph neural network for drug-target interaction prediction

Regulation-aware graph learning for drug repositioning over heterogeneous biological network

A foundation model for clinician-centered drug repurposing

HGTDR: Advancing Drug Repurposing with Heterogeneous Graph Transformers

iGRLDTI: An Improved Graph Representation Learning Method for Predicting Drug-Target Interactions over Heterogeneous Biological Information Network

Drug-Target Affinity Prediction Based on Improved GraphDTA

Drug Repositioning Method Based on Deep Neural Network

Drug repurposing against breast cancer by integrating drug-exposure expression profiles and drug–drug links based on graph neural network

A novel efficient drug repurposing framework through drug-disease association data integration using convolutional neural networks